منابع مشابه
Hydroxychloroquine screening.
A lmony et al report in this issue of the BJO (p 569) the use of a threshold Amsler grid (TAG) as a screening tool for asymptomatic patients taking hydroxychloroquine (HCQ). They studied 56 patients taking HCQ and 12 controls. Patients were tested with a ‘‘white on black’’ Amsler grid (AG), a ‘‘red on black’’ AG (RAG), and the threshold AG (TAG). TAG uses cross polarising filters to reduce the ...
متن کاملHydroxychloroquine retinopathy screening.
AIM To compare current hydroxychloroquine retinopathy screening practices with the published 2002 American Academy of Ophthalmology (AAO) Preferred Practice Patterns (PPP). METHODS A multiple-choice survey was distributed to 105 ophthalmologists to assess current screening practices and knowledge of patient risk factors. Results were compared with the PPP guidelines. A cost analysis of the PP...
متن کاملHydroxychloroquine retinopathy: screening needed to prevent blindness.
TO THE EDITOR: I note the letter in the 7 June issue of the Journal by Ojaimi and colleagues, in which they express their concerns about the lack of uniform screening guidelines for patients on hydroxychloroquine therapy. The most obvious problem was the apparent failure of the treating rheumatologist to ensure that the patient was adequately followed up for ocular side effects associated with ...
متن کاملComparison of screening procedures in hydroxychloroquine toxicity.
OBJECTIVES To compare different screening procedures for hydroxychloroquine sulfate (Plaquenil) toxicity at different stages of damage. METHODS Ten patients were studied using 10-2 automated fields, multifocal electroretinography, spectral domain optical coherence tomography (SD-OCT), and fundus autofluorescence. RESULTS All 10 patients used hydroxychloroquine for more than 6 years, and tho...
متن کاملOcular toxicity and hydroxychloroquine: guidelines for screening.
Chloroquine and hydroxychloroquine (4-aminoquinolones) are used by dermatologists for the treatment of a wide range of disorders. It is widely recognized that their use may lead to ocular complications, but policies for ophthalmological screening and follow-up vary widely. In this article, the current literature on the ocular complications of antimalarials is reviewed, together with the results...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 2005
ISSN: 0007-1161
DOI: 10.1136/bjo.2004.061473